Laura E Kwako

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study
    Laura E Kwako
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive, 1 3330, Bethesda, MD, 20892 1108, USA
    Psychopharmacology (Berl) 232:295-304. 2015
  2. doi request reprint Traumatic brain injury in intimate partner violence: a critical review of outcomes and mechanisms
    Laura E Kwako
    National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA
    Trauma Violence Abuse 12:115-26. 2011
  3. doi request reprint Major depressive disorder in persons exposed to trauma: relationship between emotional intelligence and social support
    Laura E Kwako
    National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA
    J Am Psychiatr Nurses Assoc 17:237-45. 2011
  4. doi request reprint Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes
    Laura E Kwako
    Laboratory for Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA
    Addict Biol 20:733-46. 2015
  5. pmc The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study
    Laura E Kwako
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
    Neuropsychopharmacology 40:1053-63. 2015

Detail Information

Publications5

  1. pmc The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study
    Laura E Kwako
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive, 1 3330, Bethesda, MD, 20892 1108, USA
    Psychopharmacology (Berl) 232:295-304. 2015
    ..The NK1 antagonist aprepitant, clinically available as a treatment for chemotherapy-induced nausea, offers a tool to probe a potential role of the SP/NK1 system in comorbid PTSD and alcoholism...
  2. doi request reprint Traumatic brain injury in intimate partner violence: a critical review of outcomes and mechanisms
    Laura E Kwako
    National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA
    Trauma Violence Abuse 12:115-26. 2011
    ....
  3. doi request reprint Major depressive disorder in persons exposed to trauma: relationship between emotional intelligence and social support
    Laura E Kwako
    National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA
    J Am Psychiatr Nurses Assoc 17:237-45. 2011
    ....
  4. doi request reprint Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes
    Laura E Kwako
    Laboratory for Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA
    Addict Biol 20:733-46. 2015
    ..Further research is warranted to better understand the mechanisms behind craving induced by stress versus alcohol cues, as well as to understand the impact of co-morbid PTSD and AD on craving. ..
  5. pmc The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study
    Laura E Kwako
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
    Neuropsychopharmacology 40:1053-63. 2015
    ..Our results may indicate that antagonists with slow offset are required for therapeutic efficacy. Alternatively, the extensive preclinical data on CRH1 antagonism as a mechanism to suppress alcohol seeking may not translate to humans. ..